This study compared the cardiac output responses to haemodynamic interventions as measured by three minimally invasive monitors (Oesophageal Doppler Monitor, the VigileoFlotrac and the LiDCOrapid) to the responses measured concurrently using thermodilution, in cardiac surgical patients. The study also assessed the precision and bias of these monitors in relation to thermodilution measurements.
The use of minimally invasive cardiac output monitors to guide goal-directed therapy has been shown to improve patient outcomes in some studies 1 . They offer the potential to replace the pulmonary artery catheter (PAC) where it is used, for example in cardiac surgery, or to provide additional monitoring in patients who have traditionally not had cardiac output (CO) monitoring 2 . Trends have shown a reduction in the use of the PAC in cardiac surgery with the concern that rare but serious complications, such as pulmonary artery rupture, outweigh the benefits 3 . However, the choice of monitoring systems and their utility needs further assessment for perioperative use 4 . The two most promising technologies are the oesophageal Doppler and arterial pressure waveform devices, which have been used to optimise oxygen delivery in an attempt to improve patient outcomes 2 .
The aim of this study was to assess the performance three such devices; the oesophageal Doppler (OD, CardioQ™, Deltex Medical, Chichester, West Sussex, UK), FloTrac/Vigeleo™ (FT, Edwards Lifesciences, Irvine, CA, USA) and LiDCOrapid™ (Li, LiDCO Pty Ltd, Cambridge, Cambridgeshire, UK) in comparison to bolus thermodilution (TD) with a PAC.
The OD requires insertion of a single-use oesophageal probe, consisting of a plastic tube 9 mm in diameter with a 5.1 MHz transducer angled at 45 degrees, to obtain a spectral Doppler trace from the descending aorta. It derives the CO from the velocity time integral of the Doppler trace, an estimation of the cross-sectional area of the aorta (using a nomogram based on age, weight and height) and an assumption that 70% of the cardiac output reaches the descending aorta 5 . In untrained clinicians, one study found that it requires experience in no more than 12 patients to obtain reliable CO measurements 6 . The variability of sequential OD readings has been estimated to be ≤8%, which compares favourably to thermodilution 7 .
The FT system is an uncalibrated arterial pressure waveform device that estimates stroke volume as k × pulsatility 8 . Pulsatility is the standard deviation of the arterial pressure wave over a 20 second interval. k is a proprietary factor for quantifying arterial compliance and vascular resistance. It is requires an adequate arterial waveform without significant damping.
The Li is also an uncalibrated arterial pressure waveform device, which uses a frequency analysis of the arterial system using proprietary software, PulseCO™ (LiDCO Pty Ltd, Cambridge, Cambridgeshire, UK), and relies on net power rather than arterial waveform morphology 9 . The Li does not measure CO using lithium indicator dilution, unlike the LiDCOplus™, produced by the same company (LiDCO Pty Ltd, Cambridge, Cambridgeshire, UK), making it simpler to use but losing the advantage of calibration.
Previous assessments of new CO monitors have often relied on Bland-Altman analysis to calculate bias and precision compared to thermodilution. Few studies have looked at the performance of CO devices in a clinical setting with changing haemodynamics. However, in a study looking at haemodynamically unstable patients, the accuracy of FT compared with transpulmonary thermodilution was unacceptably poor (percentage error 58.8%) 10 . Observations from clinicians also highlight the potential for poor performance of arterial pressure derived CO devices in challenging clinical situations with changing haemodynamics 11, 12 .
Assessment of CO monitors needs to go beyond measures of accuracy based only on bias and precision. The ability to track the CO changes to common clinical interventions is of greater relevance. Clinical studies using goal-directed fluid therapy to improve patient outcomes, require tracking of changes to CO after a fluid bolus to optimise oxygen delivery 13 . Vasopressor administration is another common clinical intervention and offers a challenge, particularly to arterial pressure devices and the ability of their proprietary algorithms to distinguish between changes in arterial impedance and CO.
The aim of this study was therefore to assess not only the bias and precision of these three devices in relation to TD measurements, but also the concordance of the cardiac output responses to fluid and vasopressor administration.
METHOD
Approval from our local ethics committee (St Vincent's Hospital, Melbourne, Victoria, ref HREC-D 050/08) with written consent was obtained prospectively and the study is registered with the Australian and New Zealand clinical trial register (ACTRN12609000407291). We evaluated 15 adult cardiac patients having elective open heart surgery between May and October 2009. All elective open heart surgery patients were eligible for inclusion if an investigator was available. Patients with atrial fibrillation, a preoperative diagnosis of significant tricuspid or aortic regurgitation or a contraindication to an oesophageal probe were excluded. All patients were monitored using TD as the reference method, and the three test devices.
A PAC (4 Lumen 7.5F Swan Ganz catheter, Edwards Lifesciences, Irvine, CA, USA) and radial arterial line (20 G, Angiocath™, Dickinson Infusion Therapy Systems, Sandy, Utah, USA) were inserted in the sedated patient prior to induction of general anaesthesia. An anaesthetic was given based on midazolam, fentanyl and propofol induction with sevoflurane maintenance. The choice of muscle relaxant was left to the anaesthetist. The arterial line was connected to the FT transducer which has two output cables, providing a signal to both the FT device and the anaesthetic monitor, a Datex-Ohmeda S/5. The Li obtains the arterial waveform for analysis via a cable from the anaesthetic monitor. The OD probe was inserted after induction of general anaesthesia by one of three investigators, all of whom were experienced in its use in well over 12 patients. The investigator was blinded to the TD readings until the completion of readings from the OD and FT devices. The anaesthetist and surgical team were blinded to the test device readings, but not the TD measurements.
The internal clocks of all devices were synchronised to allow verification of accuracy of data acquisition using trend analysis at the end of the case, in particular that measurements were within the same time epoch for all devices. Recording a set of haemodynamic readings occurred in the following manner: the anaesthetist, blinded to the test devices, would start a set of five TD readings. After the first TD reading and before the last TD reading, the investigator would obtain and record the OD measurement and FT readings. The Li monitor was used to create a time marker which would serve to pinpoint the period when the trends were analysed offline.
OD readings comprised the cardiac index (CI OD ) and stroke volume index (SVI OD ); the parameters are updated every 30 seconds from an average of five cardiac cycles. FT readings, updated every 60 seconds, comprised the cardiac index (CI FT ) and stroke volume index (SVI FT ). FT software version 1.14 was current at the start of the study (used for first four patients), but was updated to version 3.0 (11 patients), designed to improve accuracy in hyperdynamic situations. (This did not represent a major upgrade and was not expected to change the performance of the device in this study population.) Li readings comprised cardiac index (CI Li ) and stroke volume index (SVI Li ), which are displayed on a beatto-beat basis, but analysed as a 20 second average in order to be consistent with FT which calculates its key parameters every 20 seconds. We performed intermittent bolus TD using the PAC with 10 ml of 0.9% sodium chloride solution at room temperature 14 .
All rapid fluid infusions were ceased during the measurement period. In order to obtain an accurate estimation of the CO, we took the mean of five readings throughout the respiratory cycle. The mean TD cardiac index was then calculated (CI TD ); obvious outliers (>20% difference) and measurements from abnormal curves were excluded 15 .
Readings from the OD and the FT were entered into a spreadsheet as they were taken, followed by TD readings when completed. Basic physiological variables (blood pressure, heart rate) and readings from Li were analysed offline using the LiDCOview™ (LiDCO Pty Ltd, Cambridge, Cambridgeshire, UK) program, which automatically archives all Li data.
Readings were taken after general anaesthetic induction but before sternotomy, after sternal closure and for up to two hours in the intensive care unit. The period where the sternum was open was not studied because intraoperative transoesophageal echocardiography and cardiopulmonary bypass did not allow for the use of all the devices. The investigator undertook readings every 15 minutes and when there was a significant change (>10%) in the patient's blood pressure or heart rate.
In addition, responses to specific interventions were also measured. These interventions were a fluid bolus of 250 ml or more of crystalloid, colloid or blood product given at the discretion of the anaesthetist, or the administration of metaraminol (0.5 mg) to increase systemic vascular resistance. The post-event readings were taken when any haemodynamic change had plateaued for a minimum of 60 seconds. This allowed all three devices adequate time to update their readings. A response was only measured when there was a single intervention occurring. Events also had to be free of confounders such as changes in patient position or change in depth of anaesthesia.
STATISTICS
The CO response (increase or decrease) to fluid and vasopressor as measured by each of the devices was presented as a frequency table. Agreement of each monitor with TD was assessed with Cohen's kappa statistic after dividing ΔCI (change in cardiac index) into three categories: a fall of ≥10%, a change of <10% and a rise of ≥10%.
We analysed paired CI measurements using Bland-Altman analysis to determine bias and limits of agreement (limits of agreement=mean±2SD) of each test device compared to TD and corrected for multiple observations per individual 16 . The precision was also displayed as percentage error (2SD/mean CI), which removes the distorting effect of the absolute value of CI that may vary greatly depending on the patient. All analyses were performed using Stata 10™ (StataCorp LP, College Station, TX, USA).
RESULTS
A total of 15 patients were studied. We obtained measurements suitable for analysis from all patients. The study population had an average age of 66.6 years (SD 8.9), height 176.0 cm (9.3), weight 85.8 kg (10.7) and body mass index 30.8 (3.6) .
Change in cardiac index following fluid administration
There were 22 isolated fluid interventions assessed in 15 patients with a range of one to three per patient; 19 events involved the administration of 250 ml of colloid or blood; one 350 ml of colloid; one 500 ml of colloid and one 250 ml of crystalloid. CI TD increased in 82% of the interventions (Table 1) while CI OD , CI FT and CI Li increased in 68%, 57% and 41% of interventions respectively. Figure 1 plots ΔCI TD versus each of the test devices following a fluid event. Table 2 shows percentage agreement and kappa statistic for ΔCI test device compared to ΔCI TD after a fluid event. When compared to TD, the test devices displayed only fair agreement with kappas of OD 0.34, Li 0.28 and FT -0.03 (n=22 events).
Change in cardiac index following vasopressor administration
There were 11 vasopressor interventions (metaraminol 0.5 mg) assessed in 10 patients. With the administration of vasopressor, CI TD increased in 55% of the interventions (Table 3) while CI OD , CI FT and CI Li increased in 18%, 55% and 82% of interventions respectively.
Bland-Altman analysis
We obtained 100 paired measurements in 15 patients, with a range of 2 to 11 paired readings per patient (Figure 2 , Bland-Altman plots). Table  4 displays the bias and precision of the test devices in comparison to TD. The precision is presented as limits of agreement (bias±2SD) which can also be expressed as a percentage of the mean cardiac index, that is percentage error equals 2SD/mean CI. In comparison to TD, the percentage error was OD 64.5%, FT 47.6% and Li 54.2%.
DISCUSSION
The response to interventions by minimally invasive CO devices is integral to their use as haemodynamic monitors, especially to guide goal-directed therapy. Yet their responses have been poorly studied and inconsistently reported in comparison to bias and precision. Studies that report on the ability of devices to track changes in CO commonly present correlation coefficients or percentage agreement for sequential measurements separated by a predefined time period 17, 18 . For example, the change in measured CO by OD has shown high correlation with TD (r=0.9) when two consecutive measurements are separated by a median time of 1.5 hours 19 . In another study, arterial pressure based CO devices showed agreement of 81% in comparison to TD 20 when the measurements were taken at predefined clinical events (e.g. sternotomy).
The current study specifically investigated changes in CO after common clinical interventions rather than at predetermined times or clinical stages. This is likely to be closer to the way a clinician would use the CO monitors intraoperatively. We found that the three test devices appeared to differ from TD in their response to a fluid bolus. They registered an increase in CO with different frequencies, i.e. TD 82% of fluid interventions, OD 68%, FT 57% and Li only 41%.
In order to describe agreement of the test devices with TD, we used the kappa statistic, which unlike the commonly used percentage agreement takes into account chance agreement 21 . The agreement was only fair for the OD (k=0.33 with 63.6% agreement) and Li (k=0.28, 54.6%) and poor with the FT (k=-0.03, 33.3%) in tracking a change in CO after a fluid bolus. Put simply, the ability of the devices to agree with changes in CI TD after a fluid bolus appeared to be slightly or no better than chance.
We also found that TD and the three devices differed in their response to administration of a vasopressor. Interestingly, the OD more frequently registered a fall in CO after vasopressor administration compared to the other devices. A previous study found that arterial pressure derived CO devices tended to have a dependence on arterial waveform morphology, causing them to register an increase in cardiac output when TD would suggest it remains constant or decreases following vasopressor administration 22 . While there are many studies and a meta-analysis of the OD in goal directed therapy trials 1 , there is little data with arterial pressure derived CO devices. Yet, if proprietary minimally invasive CO devices differ significantly in their assessment of CO responses to fluid and vasopressor events, they should not be considered interchangeable technologies for purposes such as tracking haemodynamic changes or fluid optimisation. Our results suggest that further studies specific to each proprietary CO monitor are needed to evaluate their clinical utility.
While the devices had minimal bias, we report a percentage error range of FT 47.6%, Li 54.2% to OD 64.5% when the test devices were compared to TD. The most commonly cited acceptable upper limit of percentage error has been <30% by Critchley and Critchley 23 ; a conclusion based largely on measurements at steady state conditions outside of the operating room where measurements of CO by commercial TD devices can vary by 13% between sequential readings 24 . Intraoperatively, there is an even greater variation in the reference TD method, which in a porcine model had a percentage error of 40% (bias -0.69, ±1.58 l/minute) when it was compared with a reference standard, a much a more invasive aortic flow device 25 . Continuous TD techniques may be associated with even poorer precision than intermittent bolus TD 26 . The inherent variability, or error, of the TD technique places wider limits on the precision than can be expected from any test monitor, no matter how accurate, and has led to calls for a more realistically acceptable percentage error of 42 to 45% 18, 27 . The uncertainty about the usefulness of measures of bias and precision highlights the need for studies investigating how monitors track clinically relevant haemodynamic changes.
In a recent review, the OD had a percentage error of 65% from 11 studies 23 , which is similar to our finding. The arterial pressure derived CO devices demonstrate a range of percentage errors, reflecting different clinical conditions and study methodology. The percentage error of FT has been reported as 43%, 47.6% and 56% 18, 22, 28 , while the Li, with the underlying algorithm PulseCO, has been demonstrated to have percentage errors of 26 to 29% 29, 30 . Despite having a higher percentage error, we found that the OD did not perform any worse in tracking events.
The limited patient numbers and interventions does not allow us to discriminate between the monitors in terms of accuracy or to rank them by agreement to other technologies. Moreover, our findings are presented in a descriptive manner, because the small numbers were unlikely to have sufficient power for meaningful inferential analysis. Nevertheless, the extremely wide variation between devices clearly indicates that results based on one technology should not be extrapolated to other technologies. For this reason, it would not be possible to infer that the positive outcomes from goal directed therapy studies based on OD 1 would apply when other minimally invasive CO monitors are used to guide fluid therapy.
Measurement of CO with four monitors concurrently presents a challenge in ensuring the timing of the readings themselves are not a source of error. We attempted to minimise this by making sure that the measurements were synchronised within the period of TD readings and to each device. The devices were also used as directed by the manufacturer's instructions; for example, allowing enough time for recalibration of the arterial pressure devices.
Another potential issue with concurrent assessment of multiple monitors is that they may interfere with each other's measurements. Of the two arterial pressure devices, Li uses an algorithm based on pulse power, which is less dependent on waveform morphology, while FT uses pulse contour analysis. As a result, using the proprietary FT transducer and cable system should not interfere with Li measurements. The minimal manipulations of the OD probe to optimise readings did not cause haemodynamic changes during general anaesthesia and ultrasound itself would not be expected to cause any haemodynamic changes. With TD, the volume of injectate (5×10 ml) would represent a small and as yet an unstudied influence on the CO determinations of other devices. On balance, we consider that the likelihood of significant interference between the devices was extremely low.
Perhaps the tests of accuracy and agreement that we have used are not as sensitive as the skill of the experienced observer in analysing trends. For example, a single fall in CO may not be as important as a sustained trend of lower CO readings over time.
In addition to accuracy, other factors would also need to be considered in the choice of CO devices 2,31 . Finally, this study population of cardiac surgery patients may make the findings less generalisable to other patients. For example, the use of cardiopulmonary bypass and the associated reduction in systemic vascular resistance could challenge the ability of arterial pressure derived CO monitors to track changes in arterial capacitance.
In conclusion, our findings indicate that in cardiac surgical patients, the OD, FT and Li differ in their responses, do not always provide the same
